Author:
Mohnike Wolfgang,Hör Gustav,Schelbert Heinrich
Publisher
Springer Berlin Heidelberg
Reference40 articles.
1. Academy of Molecular Imaging (2005) Molecular Imaging and Biology (Scientific Abstracts of the 2005 Annual Conference of the Academy of Molecular Imaging, Orlando, Florida). Springer, Heidelberg, S 79–180
2. Bangerter M, Kotzerke J, Grieshammer M et al. (1999) Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest. Acta Oncol 38: 799–804
3. Baum RP, Niesen A, Hertel A, Adams S, Kojouharoff B, Goldenberg DM, Hör G (1994) Initial clinical results with technetium-99mlabeled LL2 monoclonal antibody fragment in the radioimmunodetection of B-cell lymphomas. Cancer 73: 896–899
4. Cremerius U, Fabry U, Wildberger JE et al. (2002) Pre-transplant positron emission tomography (PET) using fluorine-18-fluorodeoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin’s lymphoma. Bone Marrow Transplant 30: 103-111
5. Deutsche Gesellschaft für Nuklearmedizin (2004) Empfehlungen der Strahlenschutzkommission (Anwendung der Positronenemissionstomographie [PET] als effizientes dosissparendes Diagnoseverfahren). Nuklearmedizin PET 3: N35–N36